HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Loehr, B. I. Articles by van Drunen Littel-van den Hurk, S. Search for Related Content PubMed PubMed Citation Articles by Loehr, B. I. Articles by van Drunen Littel-van den Hurk, S. Agricola Articles by Loehr, B. I. Articles by van Drunen Littel-van den Hurk, S.

Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine

Veterinary Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Rd, Saskatoon, Saskatchewan, CanadaS7N 5E3¹

Author for correspondence: Sylvia van Drunen Littel-van den Hurk. Fax +1 306 966 7478. e-mail vandenhurk{at}sask.usask.ca

DNA vaccines have several advantages over conventional vaccines. One of the most important characteristics is the presentation of antigen via both MHC class I and class II receptors. Although this generally results in strong T-cell responses, antibody production and protection achieved by DNA immunization are unfortunately not always adequate. In contrast, modified live virus (MLV) vaccines usually induce adequate antibody and moderate cellular responses, whereas killed vaccines tend to elicit weak immune responses in general. A DNA prime–MLV boost regimen should result in enhanced cellular immunity and possibly improved antibody production. To test this hypothesis, plasmids encoding bovine herpesvirus-1 (BHV-1) glycoproteins B and D were delivered by gene gun to the genital mucosa of cattle prior to immunization with modified live BHV-1 vaccine. The immune responses induced were compared to those of an MLV-vaccinated group and a negative control group. Although significantly enhanced T-cell responses were induced by priming with the DNA vaccine, there was no increase in antibody titres. Similar levels of protection were induced by the MLV vaccine alone and the DNA prime and MLV boost regimen, which suggests that there is no correlation between the induction of T-cell responses and protection from BHV-1 challenge.

This article has been cited by other articles:

				C. Zheng, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Bovine Herpesvirus 1 VP22 Enhances the Efficacy of a DNA Vaccine in Cattle J. Virol., February 1, 2005; 79(3): 1948 - 1953. [Abstract] [Full Text] [PDF]

				R. A. Pontarollo, L. A. Babiuk, R. Hecker, and S. van Drunen Littel-van den Hurk Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors J. Gen. Virol., December 1, 2002; 83(12): 2973 - 2981. [Abstract] [Full Text] [PDF]

				X. P. Ioannou, P. Griebel, R. Hecker, L. A. Babiuk, and S. van Drunen Littel-van den Hurk The Immunogenicity and Protective Efficacy of Bovine Herpesvirus 1 Glycoprotein D plus Emulsigen Are Increased by Formulation with CpG Oligodeoxynucleotides J. Virol., August 12, 2002; 76(18): 9002 - 9010. [Abstract] [Full Text] [PDF]